Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multi-center, Double-blind, Two-armed, Parallel Active Groups, Prospective Trial, to Evaluate, in Pediatric Population, the Efficacy and Safety of Chloroprocaine 1% and 2% for Peripheral Nerve Block.

NCT03918798 is registered in ClinicalTrials.gov with Sintetica SA as lead sponsor.

NCT NCT03918798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03918798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multi-center, Double-blind, Two-armed, Parallel Active Groups, Prospective Trial, to Evaluate, in Pediatric Population, the Efficacy and Safety of Chloroprocaine 1% and 2% for Peripheral Nerve Block.
Lead sponsor
Sintetica SA
Phase
Phase 2
Overall status
Completed
Start date
February 14, 2019
Completion date
October 17, 2025
Enrollment
164 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

flat foot, hernia, inguinal